Potential crosstalk between insulin-like growth factor receptor type 1 and epidermal growth factor receptor in progression and metastasis of pancreatic cancer

被引:39
|
作者
Ueda, Shigeto
Hatsuse, Kazuo
Tsuda, Hitoshi
Ogata, Sho
Kawarabayashi, Nobuaki
Takigawa, Toshimichi
Einama, Takahiro
Morita, Daisaku
Fukatsu, Kazuhiko
Sugiura, Yoshiaki
Matsubara, Osamu
Mochizuki, Hidetaka
机构
[1] Natl Def Med Coll, Dept Pathol 2, Tokorozawa, Saitama 3598513, Japan
[2] Natl Def Med Coll, Dept Surg 1, Tokorozawa, Saitama 359, Japan
[3] Natl Def Med Coll, Dept Lab Med, Tokorozawa, Saitama 359, Japan
[4] Natl Def Med Coll, Dept Surg 2, Tokorozawa, Saitama 359, Japan
[5] Natl Def Med Coll, Dept Basic Traumatol, Tokorozawa, Saitama 359, Japan
关键词
EGFR; IGF1R; immunohistochemistry; pancreatic cancer;
D O I
10.1038/modpathol.3800582
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The insulin-like growth factor receptor type 1 (IGF1R) and epidermal growth factor receptor ( EGFR) are reportedly overexpressed in pancreatic cancer. However, the correlation between activated EGFR and IGF1R and their clinicopathological implications still remain unclear. The cellular localization and overexpression of IGF1R and EGFR were investigated immunohistochemically in primary invasive ductal pancreatic carcinomas obtained from 74 patients who underwent radical surgical resection. We also compared the status of IGF1R and EGFR overexpression between primary tumors and hepatic metastatic tumors obtained from 44 autopsied patients. Among the 74 surgically resected primary tumors, cytoplasm- and membrane-dominant EGFR overexpression was detected in 22 (30%) and 7 (9%), respectively, whereas cytoplasm- and membrane-dominant IGF1R overexpression was detected in 8 (11%) and 28 (38%), respectively. Membrane-dominant EGFR and cytoplasm- dominant IGF1R were more frequent in lower-grade tumors and correlated with favorable prognosis, whereas cytoplasm- dominant EGFR and membrane-dominant IGF1R were more frequent in higher-grade tumors and correlated with poor prognosis. In 36 autopsy specimens of pancreatic tumor with concurrent overexpression of IGF1R and EGFR, there was an inverse correlation between the IGF1R and EGFR localization patterns (P = 0.001). In the hepatic metastatic tumors obtained by autopsy, the incidences of both IGF1R and EGFR overexpression were much higher than in the surgically resected primary tumors. More than half of the autopsy cases consistently showed membrane-dominant EGFR expression in both the primary tumor and hepatic metastases, whereas IGF1R expression showed considerable variation. Crosstalk between differently localized IGF1R and EGFR might play a role in determining the biological aggressiveness of pancreatic cancer, although their cellular localization may often alter during the process of metastasis.
引用
收藏
页码:788 / 796
页数:9
相关论文
共 50 条
  • [1] Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
    van der Veeken, J.
    Oliveira, S.
    Schiffelers, R. M.
    Storm, G.
    Henegouwen, P. M. P. van Bergen En
    Roovers, R. C.
    CURRENT CANCER DRUG TARGETS, 2009, 9 (06) : 748 - 760
  • [2] Signalling by the type 1 insulin-like growth factor receptor: Interplay with the epidermal growth factor receptor
    Adams, TE
    McKern, NM
    Ward, CW
    GROWTH FACTORS, 2004, 22 (02) : 89 - 95
  • [3] Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
    Subramani, Ramadevi
    Lopez-Valdez, Rebecca
    Arumugam, Arunkumar
    Nandy, Sushmita
    Boopalan, Thiyagarajan
    Lakshmanaswamy, Rajkumar
    PLOS ONE, 2014, 9 (05):
  • [4] Targeting Insulin-like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
    Subramani, Ramadevi
    Lopez, Rebecca
    Arumugam, Arunkumar
    Nandy, Sushmita B.
    Boopalan, Thiyagarajan
    Lakshmanaswamy, Rajkumar
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [5] Clinical significance of insulin-like growth factor type 1 receptor and epidermal growth factor receptor in patients with advanced gastric cancer
    Matsubara, Junichi
    Yamada, Yasuhide
    Nakajima, Takako E.
    Kato, Ken
    Hamaguchi, Tetsuya
    Shirao, Kuniaki
    Shimada, Yasuhiro
    Shimoda, Tadakazu
    ONCOLOGY, 2008, 74 (1-2) : 76 - 83
  • [6] Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer
    Tian, Xiaodong
    Hao, Kun
    Qin, Changfu
    Xie, Kun
    Xie, Xuehai
    Yang, Yinmo
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (09) : 2705 - 2712
  • [7] Insulin-Like Growth Factor 1 Receptor Promotes the Growth and Chemoresistance of Pancreatic Cancer
    Xiaodong Tian
    Kun Hao
    Changfu Qin
    Kun Xie
    Xuehai Xie
    Yinmo Yang
    Digestive Diseases and Sciences, 2013, 58 : 2705 - 2712
  • [8] Expression and clinical significance of epidermal growth factor receptor and type 1 insulin-like growth factor receptor in nasopharyngeal carcinoma
    Yuan, Yulin
    Zhou, Xuhong
    Song, Jian
    Qiu, Xiaoping
    Li, Jun
    Ye, Linfeng
    Meng, Xiaoping
    Xia, Dong
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2008, 117 (03): : 192 - 200
  • [9] Intracellular transactivation of the insulin-like growth factor I receptor by an epidermal growth factor receptor
    Burgaud, JL
    Baserga, R
    EXPERIMENTAL CELL RESEARCH, 1996, 223 (02) : 412 - 419
  • [10] How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
    Xu, Yibin
    Margetts, Mai B.
    Venugopal, Hari
    Menting, John G.
    Kirk, Nicholas S.
    Croll, Tristan I.
    Delaine, Carlie
    Forbes, Briony E.
    Lawrence, Michael C.
    STRUCTURE, 2022, 30 (08) : 1098 - +